A. Khalil

发表

Adaptive radiotherapy of lung cancer patients with pleural effusion or atelectasis.

Lone Hoffmann, Ditte Sloth Møller, D. Møller, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Role of perfusion SPECT in prediction and measurement of pulmonary complications after radiotherapy for lung cancer

C. Grau, A. Khalil, K. Farr, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours.

M. Josipovic, G. Persson, W. Ottosson, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation.

C. Grau, J. Overgaard, M. Horsman, 1994, International journal of radiation oncology, biology, physics.

Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model.

C. Grau, J. Overgaard, M. Horsman, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Local control after stereotactic body radiotherapy of centrally located lung tumours

T. B. Nyeng, D. Møller, A. Khalil, 2021, Acta oncologica.

Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays

E. Nexo, A. Khalil, B. Sorensen, 2014, BMC Cancer.

A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients

L. Muren, D. Møller, A. Khalil, 2011, Acta oncologica.

A Retrospective Study of Palliative Cisplatin-Based Doublet Chemotherapy for Malignant Pleural Mesothelioma

A. Khalil, P. Meldgaard, S. F. Sorensen, 2014 .

Assessment of very early response evaluation with 18F-FDG-PET/CT predicts survival in erlotinib treated NSCLC patients-A comparison of methods.

A. Khalil, J. Frøkiær, P. Meldgaard, 2018, American journal of nuclear medicine and molecular imaging.

Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum

J. Overgaard, J. Alsner, M. Horsman, 2005, International journal of radiation biology.

Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy

A. Khalil, M. Knap, L. Hoffmann, 2015, Acta oncologica.

18 FDG-PET/CT Is a Useful Tool in Staging Procedure before Chemo-Radiotherapy in Patients with Limited Disease Small-Cell Lung Cancer. Pattern of Failure and Survival Is Analyzed

A. Khalil, M. Knap, P. Meldgaard, 2012 .

Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2′‐deoxy‐2′‐[18F] fluoro‐D‐glucose‐PET/CT scans to predict survival early during treatment of locally advanced non‐small cell lung cancer (NSCLC)

A. Khalil, J. Frøkiær, K. Hjorthaug, 2016, Journal of medical imaging and radiation oncology.

Syddansk Universitet Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC ( the NARLAL 2 trial ) Design and early dosimetric results of a randomized , multi-centre phase-III study

M. Josipovic, G. Persson, W. Ottosson, 2018 .

The NARLAL2 dose escalation trial: dosimetric implications of inter-fractional changes in organs at risk

A. Khalil, M. Knap, L. Hoffmann, 2017, Acta oncologica.

University of Southern Denmark Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC ( the NARLAL 2 trial ) Design and early dosimetric results of a randomized , multi-centre phase-III study

M. Josipovic, G. Persson, W. Ottosson, 2018 .

Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC ( the NARLAL 2 trial )

M. Josipovic, G. Persson, W. Ottosson, 2018 .

Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.

C. Brink, M. Josipovic, G. Persson, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumour radiosensitization by nicotinamide: is it the result of an improvement in tumour oxygenation?

J. Overgaard, M. Horsman, A. Khalil, 1994, Advances in experimental medicine and biology.

Measurement of pO2 in a murine tumour and its correlation with hypoxic fraction.

C. Grau, J. Overgaard, M. Horsman, 1994, Advances in experimental medicine and biology.

The HILUS-trial - a prospective Nordic multi-center phase II study of ultra-central lung tumors treated with stereotactic body radiotherapy.

I. Lax, M. Josipovic, G. Persson, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A comparison of two methods for segmentation of functional volumes in radiotherapy planning of lung cancer patients

T. B. Nyeng, C. Grau, D. Møller, 2021, Acta oncologica.

New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy

A. Khalil, M. Knap, L. Hoffmann, 2015, Acta oncologica.

Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas.

J. Horiot, J. Bernier, S. Dische, 2003, International journal of radiation oncology, biology, physics.

Development of radiation pneumopathy and generalised radiological changes after radiotherapy are independent negative prognostic factors for survival in non-small cell lung cancer patients.

C. Grau, D. Møller, A. Khalil, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.

J. Overgaard, M. Horsman, A. Khalil, 1994, Acta oncologica.

The relationship between carbon monoxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo.

C. Grau, J. Overgaard, M. Horsman, 1994, British Journal of Cancer.

CLEP_A_326470 871..882

P. Verpillat, A. Khalil, F. Donskov, 2021 .

Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy.

M. Alber, D. Møller, A. Khalil, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial

M. Alber, C. Brink, O. Hansen, 2020, Clinical and translational radiation oncology.

Patient-reported lung symptoms and quality of life before and after radiation therapy for non-small cell lung cancer: correlation with radiation pneumonitis and functional imaging

C. Grau, A. Khalil, K. Farr, 2019, Acta oncologica.

Effect of carbon monoxide breathing on hypoxia and radiation response in the SCCVII tumor in vivo.

C. Grau, J. Overgaard, M. Horsman, 1994, International journal of radiation oncology, biology, physics.

Inclusion of functional information from perfusion SPECT improves predictive value of dose-volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: A prospective study.

C. Grau, D. Møller, A. Khalil, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.

J. Overgaard, M. Horsman, A. Khalil, 1994, Advances in experimental medicine and biology.

Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperature.

J. Overgaard, M. Horsman, A. Khalil, 1992, Acta oncologica.

OA24.05 The Nordic HILUS-Trial - First Report of a Phase II Trial of SBRT of Centrally Located Lung Tumors

I. Lax, G. Persson, R. Lewensohn, 2017 .

Time and dose-related changes in lung perfusion after definitive radiotherapy for NSCLC.

C. Grau, D. Møller, A. Khalil, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Loss of lung function after chemo-radiotherapy for NSCLC measured by perfusion SPECT/CT: Correlation with radiation dose and clinical morbidity

C. Grau, D. Møller, A. Khalil, 2015, Acta oncologica.

A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC.

C. Brink, O. Hansen, A. Khalil, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patterns of care in oligometastatic disease: the clinicians’ perspective

M. Josipovic, G. Persson, A. Khalil, 2022, Acta oncologica.

Clinicians’ Perspective On Oligometastatic Disease: A National Survey.

M. Josipovic, G. Persson, A. Khalil, 2021 .

18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non–Small Cell Lung Cancer Patients: A Comparison of Assessment Methods

A. Khalil, J. Frøkiær, P. Meldgaard, 2017, The Journal of Nuclear Medicine.

EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancer.

E. Nexo, A. Khalil, H. Hager, 2014, Lung cancer.

The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma.

J. Overgaard, M. Horsman, A. Khalil, 1995, Acta oncologica.

Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose.

Markus Alber, Lone Hoffmann, Ditte Sloth Møller, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT

H. Schmidt, A. Khalil, M. Knap, 2017, Acta oncologica.

Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer

T. B. Nyeng, A. Khalil, M. Knap, 2017, Acta oncologica.

Clinical outcome of image-guided adaptive radiotherapy in the treatment of lung cancer patients

Lone Hoffmann, D. Møller, A. Khalil, 2015, Acta oncologica.

Anatomical landmarks accurately determine interfractional lymph node shifts during radiotherapy of lung cancer patients.

Lone Hoffmann, Ditte Sloth Møller, D. Møller, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors

I. Vogelius, S. Bentzen, A. Khalil, 2014, Acta oncologica.

Prophylactic cranial irradiation in patients with small cell lung cancer. A retrospective study of recurrence, survival and morbidity.

A. Tietze, A. Khalil, M. Knap, 2012, Lung cancer.

A comparison of the physiological effects of RSU1069 and RB6145 in the SCCVII murine tumour.

C. Streffer, J. Overgaard, G. Adams, 1996, Acta oncologica.

Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy

A. Khalil, J. Frøkiær, K. Hjorthaug, 2016, EJNMMI Research.

The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation.

J. Overgaard, M. Horsman, A. Khalil, 1995, Acta oncologica.

Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy.

Yi-long Wu, C. Brink, O. Hansen, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.